Pill Identifier App

AndroGel Sales Data

Rank 35 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows AndroGel U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 35 (1) 5.47% -1.76%
Q3 2013 34 (2) -3.42% -2.99%
Q2 2013 36 (1) -0.84% -2.79%
Q1 2013 37 (1) 0.49% -40.11%
Q4 2012 36 (1) -0.34% -15.96%
Q3 2012 37 (7) 6.38% -4.66%
Q2 2012 44 (3) 4.81% -13.78%
Q1 2012 47 (6) 11.20% 4.43%
Q4 2011 53 (3) 5.44% -4.80%
Q3 2011 50 (1) -5.89% -8.93%
Q2 2011 49 (7) 6.52% 93.39%
Q1 2011 56

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
May 2, 2011Abbott Gets FDA Clearance for New Testosterone Gel
June 5, 2009Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between October - December 2008
May 7, 2009FDA Orders Label Warning for Testosterone Gels
Hide
(web2)